ClearPoint Neuro (CLPT) Short Interest Ratio & Short Volume $15.75 -0.14 (-0.88%) As of 04:00 PM Eastern Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends ClearPoint Neuro Short Interest DataClearPoint Neuro (CLPT) has a short interest of 744,200 shares. This marks a 1.09% increase in short interest from the previous month. The short interest ratio (days to cover) is 3.3, indicating that it would take 3.3 days of the average trading volume of 186,847 shares to cover all short positions.Current Short Interest744,200 sharesPrevious Short Interest736,200 sharesChange Vs. Previous Month+1.09%Dollar Volume Sold Short$11.40 millionShort Interest Ratio3.3 Days to CoverLast Record DateDecember 15, 2024Outstanding Shares27,585,000 sharesPercentage of Shares Shorted2.70%Today's Trading Volume245,241 sharesAverage Trading Volume186,847 sharesToday's Volume Vs. Average131% Short Selling ClearPoint Neuro? Sign up to receive the latest short interest report for ClearPoint Neuro and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCLPT Short Interest Over TimeCLPT Days to Cover Over TimeCLPT Percentage of Float Shorted Over Time ClearPoint Neuro Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 12/15/2024744,200 shares $11.40 million +1.1%N/A3.3 $15.33 11/30/2024736,200 shares $9.11 million -3.1%N/A3.3 $12.37 11/15/2024759,900 shares $8.31 million +10.5%N/A3.6 $10.93 10/31/2024687,600 shares $8.52 million -3.5%N/A3.3 $12.39 10/15/2024712,200 shares $8.57 million +15.2%N/A3.6 $12.04 9/30/2024618,500 shares $6.93 million -13.8%N/A3.4 $11.21 Get the Latest News and Ratings for CLPT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ClearPoint Neuro and its competitors with MarketBeat's FREE daily newsletter. 9/15/2024717,800 shares $9.04 million +1.2%N/A2.9 $12.59 8/31/2024709,400 shares $9.21 million -11.3%N/A3 $12.98 8/15/2024799,700 shares $8.67 million -0.7%N/A3.4 $10.84 7/31/2024805,400 shares $5.77 million -5.9%N/A3.6 $7.16 7/15/2024855,900 shares $6.44 million -37.5%N/A4.1 $7.52 6/30/20241,370,000 shares $7.38 million +9.6%N/A6.7 $5.39 6/15/20241,250,000 shares $6.76 million +4.2%N/A9.1 $5.41 5/31/20241,200,000 shares $6.52 million -6.3%N/A8.3 $5.43 5/15/20241,280,000 shares $8.19 million -5.9%N/A7.8 $6.40 4/30/20241,360,000 shares $7.38 million +10.6%N/A8.7 $5.43 4/15/20241,230,000 shares $6.90 million -3.9%N/A8.2 $5.61 3/31/20241,280,000 shares $8.70 million -8.6%N/A8.4 $6.80 3/15/20241,400,000 shares $10.01 million +0.7%N/A9 $7.15 2/29/20241,390,000 shares $8.88 million -2.8%N/A10.3 $6.39 2/15/20241,430,000 shares $10.65 million +3.6%N/A14.4 $7.45 1/31/20241,380,000 shares $9.60 million +3.8%N/A13.1 $6.96 1/15/20241,330,000 shares $9.54 million No ChangeN/A12.5 $7.17 12/31/20231,330,000 shares $9.03 million -8.3%N/A13.2 $6.79 12/15/20231,450,000 shares $9.03 million -0.7%N/A15.3 $6.23 11/30/20231,460,000 shares $8.41 million +0.7%N/A15.7 $5.76 11/15/20231,450,000 shares $7.16 million +0.7%N/A15.7 $4.94 10/31/20231,440,000 shares $7.92 million No ChangeN/A15.8 $5.50 10/15/20231,440,000 shares $6.67 million +13.4%N/A14.2 $4.63 9/30/20231,270,000 shares $6.36 million -1.6%N/A12.9 $5.01 9/15/20231,290,000 shares $6.63 million +3.2%N/A12.8 $5.14 8/31/20231,250,000 shares $7.26 million +10.6%N/A7.9 $5.81 8/15/20231,130,000 shares $6.78 million No ChangeN/A6 $6.00 7/31/20231,130,000 shares $7.76 million -4.2%N/A6.3 $6.87 7/15/20231,180,000 shares $7.76 million +6.3%N/A7 $6.58 6/30/20231,110,000 shares $8.04 million +53.9%N/A6.5 $7.24 6/15/2023721,100 shares $5.02 million +0.6%N/A4.3 $6.96 5/31/2023716,700 shares $5.52 million -1.8%N/A6.8 $7.70 5/15/2023729,700 shares $6.54 million +2.5%N/A9.7 $8.96 4/30/2023712,200 shares $7.49 million -6.4%N/A10.1 $10.52 4/15/2023760,700 shares $8.04 million +1.1%N/A10.3 $10.57 3/31/2023752,600 shares $6.35 million +6.6%N/A10.6 $8.44 3/15/2023706,000 shares $5.37 million -2.1%N/A9.9 $7.61 2/28/2023720,900 shares $6.11 million +0.5%N/A10.3 $8.48 2/15/2023717,000 shares $6.52 million -2.2%N/A10.3 $9.10 1/31/2023733,200 shares $6.97 million -5.7%N/A9.6 $9.51 1/15/2023777,600 shares $8.27 million -1.3%N/A9.9 $10.63 12/30/2022788,100 shares $6.68 million -1.3%N/A9.5 $8.47 12/15/2022798,600 shares $6.57 million +1.1%N/A9.3 $8.23 11/30/2022790,100 shares $7.45 million -3.3%N/A8.6 $9.43 11/15/2022816,700 shares $8.26 million -2.0%N/A8.6 $10.11 10/31/2022833,200 shares $8.34 million -3.4%N/A7.5 $10.01 10/15/2022862,300 shares $8.31 million -6.0%N/A7.4 $9.64 9/30/2022917,100 shares $9.50 million -1.9%N/A7.7 $10.36 9/15/2022934,400 shares $11.07 million +0.5%N/A5.5 $11.85 8/31/2022930,200 shares $11.97 million -12.3%N/A5.3 $12.87 8/15/20221,060,000 shares $16.98 million -15.2%N/A5.5 $16.02 7/31/20221,250,000 shares $17.71 million -3.1%6.6%6 $14.17 7/15/20221,290,000 shares $16.43 million -3.7%7.0%5.8 $12.74 6/30/20221,340,000 shares $17.49 million -28.0%7.2%5.7 $13.05 6/15/20221,860,000 shares $19.21 million +2.2%10.0%8 $10.33 5/31/20221,820,000 shares $19.95 million +0.6%9.8%9.2 $10.96 5/15/20221,810,000 shares $15.48 million +24.8%9.7%8.6 $8.55 4/30/20221,450,000 shares $12.43 million +2.8%7.8%7.2 $8.57 4/15/20221,410,000 shares $16.07 million +3.7%7.6%6.3 $11.40 3/31/20221,360,000 shares $14.16 million No Change7.3%6 $10.41 3/15/20221,360,000 shares $10.93 million +3.0%7.3%5.7 $8.04 2/28/20221,320,000 shares $11.55 million +20.0%7.1%5.1 $8.75 2/15/20221,100,000 shares $9.19 million +14.6%5.9%4.1 $8.35 1/31/2022959,600 shares $8.47 million +21.9%5.2%3.3 $8.83 1/15/2022787,400 shares $7.76 million +8.9%N/A2.8 $9.85 12/31/2021723,000 shares $8.11 million -7.4%3.8%2.7 $11.22 12/15/2021780,400 shares $9.08 million +18.4%4.1%3.1 $11.64 11/30/2021659,300 shares $9.05 million +1.0%3.5%2.9 $13.73 11/15/2021653,000 shares $10.39 million -15.1%3.5%3 $15.91 10/29/2021769,300 shares $12.87 million -4.2%4.4%3.5 $16.73 10/15/2021803,000 shares $14.42 million -6.6%4.6%3.4 $17.96 9/30/2021859,600 shares $15.26 million -6.6%4.9%3.3 $17.75 9/15/2021920,600 shares $16.55 million +7.4%5.2%2.7 $17.98 8/31/2021857,400 shares $16.18 million -38.8%5.0%2.4 $18.87 8/13/20211,400,000 shares $24.78 million +10.2%8.1%3.6 $17.70 7/30/20211,270,000 shares $28.23 million +11.4%7.9%3.4 $22.23 7/15/20211,140,000 shares $19.07 million +38.2%7.1%3.2 $16.73 6/30/2021825,000 shares $15.75 million +70.4%5.1%2.2 $19.09 6/15/2021484,100 shares $9.35 million -13.0%3.0%1.4 $19.32 5/28/2021556,200 shares $10.25 million +13.6%3.3%1.5 $18.42 5/14/2021489,600 shares $8.54 million -5.6%2.9%1.1 $17.45 4/30/2021518,400 shares $10.99 million +28.8%3.1%1.1 $21.20 4/15/2021402,600 shares $8.37 million +23.9%2.4%0.8 $20.80 3/31/2021324,900 shares $6.36 million +3.6%2.0%0.7 $19.58 3/15/2021313,600 shares $6.35 million +63.0%1.9%0.7 $20.25 2/26/2021192,400 shares $4.16 million -2.9%1.2%0.5 $21.64 2/12/2021198,100 shares $5.04 million -45.1%1.4%0.6 $25.44 1/29/2021360,800 shares $8.76 million +31.3%2.8%1.5 $24.27 1/15/2021274,800 shares $4.33 million No Change2.1%1.2 $15.76 CLPT Short Interest - Frequently Asked Questions What is ClearPoint Neuro's current short interest? Short interest is the volume of ClearPoint Neuro shares that have been sold short but have not yet been covered or closed out. As of December 15th, investors have sold 744,200 shares of CLPT short. Learn More on ClearPoint Neuro's current short interest. What is a good short interest ratio for ClearPoint Neuro? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CLPT shares currently have a short interest ratio of 3.0. Learn More on ClearPoint Neuro's short interest ratio. Is ClearPoint Neuro's short interest increasing or decreasing? ClearPoint Neuro saw a increase in short interest in December. As of December 15th, there was short interest totaling 744,200 shares, an increase of 1.1% from the previous total of 736,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does ClearPoint Neuro's short interest compare to its competitors? Here is how the short interest of companies in the industry of "medical equipment" compare to ClearPoint Neuro: InMode Ltd. (7.14%), MiMedx Group, Inc. (2.62%), RxSight, Inc. (6.74%), Establishment Labs Holdings Inc. (21.75%), BioLife Solutions, Inc. (6.75%), Artivion, Inc. (8.73%), Embecta Corp. (2.27%), Pulse Biosciences, Inc. (18.79%), Liquidia Co. (12.36%), Paragon 28, Inc. (9.02%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.32 billion), Spotify Technology S.A. ($4.06 billion), Canadian Natural Resources Limited ($3.45 billion), Reddit, Inc. ($2.79 billion), International Paper ($2.70 billion), Cencora, Inc. ($2.27 billion), SoFi Technologies, Inc. ($2.21 billion), Lululemon Athletica Inc. ($2.13 billion), and Rivian Automotive, Inc. ($2.05 billion). View all of the most shorted stocks. What does it mean to sell short ClearPoint Neuro stock? Short selling CLPT is an investing strategy that aims to generate trading profit from ClearPoint Neuro as its price is falling. CLPT shares are trading down $0.14 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against ClearPoint Neuro? A short squeeze for ClearPoint Neuro occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CLPT, which in turn drives the price of the stock up even further. How often is ClearPoint Neuro's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CLPT, twice per month. The most recent reporting period available is December, 15 2024. More Short Interest Resources from MarketBeat Related Companies InMode Short Squeeze MiMedx Group Short Squeeze RxSight Short Squeeze Establishment Labs Short Squeeze BioLife Solutions Short Squeeze Artivion Short Squeeze Embecta Short Squeeze Pulse Biosciences Short Squeeze Liquidia Short Squeeze Paragon 28 Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CLPT) was last updated on 1/6/2025 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$24 trillion tech spotted at Mar-a-Lago?President Trump’s Secret Service was recently spotted using an odd new technology at his home in Mar-a-Lago…Centurion Publishing | SponsoredFrom bankrupt to delivering 610,000% returnsWalk the empty streets of this barren town and you would have no idea that behind the sand-scarred blight is o...Porter & Company | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ClearPoint Neuro, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ClearPoint Neuro With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
